Physician profile
Christian Gulde
NPI 1679035638
$26,307.68
in general payments reported to CMS, 2019-2025
18 companies · $2,466 in 2025
The $2,466 reported for 2025 was more than what 82% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $12K · 2024: $12K · 2025: $2,466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $8,480 · Food and Beverage: $7,681 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $8,479.84 |
| Food and Beverage | $7,680.85 |
| Education | $146.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,021.83 | 2023-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $2,999.01 | 2023-2024 | Vercise, Wavewriter Alpha Prime 16, Intracept |
| Spinal Simplicity, LLC | $1,887.93 | 2024-2025 | Ha Minuteman G3-R, Liberty Si |
| Abbott Laboratories | $1,795.93 | 2023-2025 | Proclaim, Eterna, Octrode |
| Nalu Medical, INC. | $746.78 | 2023-2024 | Nalu Neurostimulation System |
| Nevro Corp. | $451.94 | 2024 | Senza |
| Foundation Fusion Solutions, LLC | $291.35 | 2024 | |
| Saluda Medical Americas, INC. | $264.91 | 2023-2024 | Evoke Scs, Evoke |
| Spr Therapeutics, INC | $226.58 | 2023-2025 | Sprint Pns System |
| Avanos Medical | $160.30 | 2023 | Generator |
| Fisher & Paykel Healthcare INC | $147.71 | 2024 | Fisher & Paykel Healthcare |
| Vertos Medical, INC. | $100.91 | 2023 | Mild Device Kit |
| Siemens Medical Solutions USA, INC. | $51.91 | 2025 | Magnetom Altea, Magnetom Free.Max |
| Stryker Corporation | $51.02 | 2023 | Spinejack |
| Abbvie INC. | $49.99 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $21.31 | 2023 | Prialt |
| Relievant Medsystems, INC. | $19.71 | 2023 | Intracept |
| Curonix LLC | $18.56 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Gulde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.